| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $24.0M | -1.8% |
| SG&A Expense | $20.0M | +50.3% |
| Operating Income | -$44.0M | -16.6% |
| Pre-tax Income | -$30.8M | +12.3% |
| Net Income | -$30.8M | +12.3% |
| EPS (Basic) | $0.78 | +129.8% |
| EPS (Diluted) | $0.78 | +129.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $269.1M | -6.9% |
| Current Assets | $272.4M | -7.0% |
| Total Assets | $277.7M | -7.0% |
| Current Liabilities | $5.4M | -4.2% |
| Total Liabilities | $8.6M | -10.2% |
| Stockholders' Equity | $269.1M | -6.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.4M | +41.5% |
| Capital Expenditures | $169K | +369.4% |
| Investing Cash Flow | -$169K | -369.4% |
| Financing Cash Flow | $799K | -99.6% |
| Free Cash Flow | -$20.6M | +41.1% |